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Background and Purpose—Besides classic criteria, cerebral perfusion imaging could improve patient selection for
thrombolytic therapy. The purpose of this study was to compare quantitative perfusion CT imaging and qualitative
diffusion- and perfusion-weighted MRI (DWI and PWI) in acute stroke patients at the time of their emergency
evaluation.
Methods—Thirteen acute stroke patients underwent perfusion CT and DWI or PWI on admission. The size of infarct and
ischemic lesion (infarct plus penumbra) on the admission perfusion CT was compared with that of the MR abnormalities
as shown on the DWI trace and on the relative cerebral blood volume, cerebral blood flow, time to peak, and mean
transit time maps calculated from PWI studies.
Results—The most significant correlation was found between infarct size on the admission perfusion CT and abnormality
size on the admission DWI map (r0.968, P0.001). A significant correlation was also observed between the size of
the ischemic lesion (infarct plus penumbra) on the admission perfusion CT and the abnormality size on the mean transit
time map calculated from admission PWI (r0.946, P0.001). Information about cerebral infarct and total ischemia
(infarct plus penumbra) carried by both imaging techniques was similar, with slopes of 0.913 and 0.905, respectively.
Conclusions—An imaging technique may be helpful in the identification of cerebral penumbra in acute stroke patients and
thus in the selection of patients for thrombolytic therapy. Perfusion CT and DWI/PWI are equivalent in this task.
(Stroke. 2002;33:2025-2031.)
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Strokes are the third-leading cause of death, after cardio-vascular diseases and cancers. Each year, they are diag-
nosed in 750 000 patients and contribute to at least 150 000
deaths in the United States.1,2 Although thrombolysis is now
an approved therapy for acute human stroke,3 many stroke
patients do not benefit from such treatment. Others even are
harmed by thrombolysis; it is responsible for up to 15% to
26% of cerebral hemorrhage.4,5 Present indications for intra-
venous thrombolytic therapy depend on the time interval
since the onset of symptoms (3 hours) and noncontrast
cerebral CT findings [absence of cerebral hemorrhage and a
cerebral hypodensity extending to less than one third of the
middle cerebral artery (MCA) territory].1,6 Many investiga-
tors believe that the selection of patients for thrombolysis
could be improved by evaluation of brain perfusion before
thrombolysis, which seems to be linked to an unfavorable
risk-to-benefit ratio in cases of extensive oligemia in the
territory of an occluded MCA.7–12 Because the aim of
thrombolysis is to save the ischemic penumbra, ie, the region
of decreased perfusion not situated below the critical level for
maintenance of the Na,K-ATPase pump and thus poten-
tially reversible,13–17 the goal in using a cerebral perfusion
imaging technique is to visualize the ischemic penumbra and
hence to identify at an early stage the difference between
undamaged and salvageable cerebral parenchyma on one
hand and unsalvageable on the other. Thrombolysis per-
formed on patients with extensive cerebral infarcts with
limited penumbra not only may prove to be of little benefit
but also may increase the risk of intracranial bleeding.8,12,18
Conventional T2-weighted images and CT studies are
typically abnormal 6 to 18 hours after the onset of ischemia.
On the other hand, diffusion- and perfusion-weighted MR
imaging (DWI and PWI) examinations have been reported to
provide an early measure of brain metabolic and hemody-
namic insufficiency as soon as minutes to hours after on-
set.7–9,19–26 Currently, many investigators hypothesize that the
DWI abnormality represents the cerebral infarct, whereas
PWI abnormalities that are not yet diffusion abnormal may
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stand for penumbra.7–9,19,27,28 This DWI-PWI mismatch at
early time points corresponds to a subsequent enlargement of
the lesion volume.26,28–31 DWI and PWI can thus improve the
selection of patients with potentially favorable outcome in
case of acute ischemic stroke.7–9,19,30–33
Perfusion CT is another imaging technique proposed for
evaluating acute stroke patients at the time of their emergency
evaluation. Perfusion CT is a modern imaging technique that
can be performed on acute stroke patients. It involves the
sequential acquisition of cerebral CT images performed in
cine mode during the intravenous administration of iodinated
contrast material. Perfusion CT has been reported to allow
accurate quantitative assessment of cerebral blood flow
(CBF) and cerebral blood volume (CBV).34 It also allows
delineation of cerebral infarct and cerebral tissue at risk for
inclusion into the final infarct according to a method vali-
dated by comparison with delayed MR.35
In this study, we prospectively evaluated acute stroke
patients by using both perfusion CT and DWI and PWI. Our
purpose was to compare and correlate the various parameters
characterizing brain perfusion that can be taken from perfu-
sion CT and MR studies.
Materials and Methods
Patients
Our series consisted of 13 consecutive acute stroke adult patients (9
men, 4 women; median age, 68 years; interquartile range, 61 to 75
years). These patients were prospectively identified in the Emer-
gency Department of our institution from March 2000 to June 2001.
Inclusion criteria included acute ischemic stroke diagnosed on the
basis of clinical and noncontrast CT data and both CT and MR
examinations performed 3 hours after symptom onset. Exclusion
criteria included potential treatment delay consecutive to performing
MR examination, as well as contraindications to iodinated contrast
material administration or to MRI. Patient characteristics, noncon-
trast CT findings, and location of the DWI abnormality are summa-
rized in Table 1.
In all 13 patients, noncontrast baseline cerebral CT was immedi-
ately followed by perfusion CT, which is included in the initial
routine survey of acute stroke patients at our institution. All 13
patients also underwent a cerebral and cervical CT-angiography.
MR examination, including sagittal T1-weighted, axial T2-
weighted, axial DWI and PWI series, as well as cerebral and cervical
MR-angiography, was performed in all 13 patients immediately after
the CT survey. The time intervals from symptom onset to admission
to the emergency room, perfusion CT, and MR were recorded. The
permeability of intracranial and extracranial cerebral vessels was
assessed from the CT-angiography, MR-angiography, and PWI.
This study protocol was approved by our review board, and
institutional informed-consent guidelines were followed.
Imaging Techniques
The perfusion CT examination consisted of two 40-second series at
an interval of 5 minutes, each series consisting of 1 image per second
in cine mode during intravenous administration of iodinated contrast
material. The acquisition parameters for both series were 80 kilovolt
(peak; kVp) and 100 mA.36 For each series, CT scanning was
initiated 7 seconds after injection of 50 mL iohexol (300 mg/mL
iodine, Accupaque 300, Nycomed) at a rate of 5 mL/s into an
antecubital vein with a power injector (CT9000, Libel-Flarsheim
Co). The time delay before contrast material reached the brain
parenchyma allowed baseline images without contrast enhancement
to be acquired. Waiting 5 minutes between the 2 perfusion CT series
allows a substantial lowering of iodinated contrast material blood
concentration after the first intravenous administration of iodinated
contrast material and a restitution of baseline. Thus, realization of the
second perfusion CT series is not affected by the first intravenous
administration of iodinated contrast material.
Multidetector-array technology (Lightspeed CT unit, General
Electric) allowed data acquisition from 2 adjacent 10-mm sections
for each series. The 2 perfusion CT series thus allowed data
acquisition in 4 adjacent 10-mm cerebral CT sections. The 4 studied
cerebral sections were selected above the orbits to protect the lenses,
running through the basal nuclei and then toward the vertex. They
were identical to 4 among the 10-mm-thick noncontrast CT slices.
The cerebral and cervical CT-angiography was performed with the
following parameters: 120 kVp; 240 mA; slice thickness, 2.5 mm;
slice acquisition interval, 2 mm; pitch, 1.5:1; intravenous adminis-
tration, 50 mL iodinated contrast material at 3 mL/s; and acquisition
delay, of 10 seconds. Data acquisition was performed from the origin
of the aortic arch branch vessels to the circle of Willis.
The MR examination was performed with a 1.5-T MR unit
(Symphony MR unit, Siemens). It included DWI series: echoplanar
single shot spin echo; repetition time (TR), 5000 ms; echo time (TE),
100 ms; b0, 500, and 1000; twenty 5-mm-thick slices with a
1.5-mm gap; and matrix size, 128128. PWI series was performed
immediately afterward: echoplanar gradient echo; TR, 120 ms; TE,
45 ms; eleven 5-mm-thick slices with a 1.5-mm gap; matrix size,
128128; and 50 acquisitions obtained every 1.32 seconds during
intravenous administration of 0.2 mmol/kg Gd-DTPA (Omniscan,
Nycomed Amersham), followed by a 15-mL saline flush at a rate of
5 mL/s into an antecubital vein with a power injector (Spectris MR
Injection System, Medrad). T2*-weighted gradient-echo imaging tech-
nique rather than T2-weighted spin-echo echoplanar imaging technique
was performed as required by the clinical trials in which the 13 patients
were involved. For cerebral and cervical vessels, MR-angiography was
performed using a time-of-flight multislab 3-dimensional fast low-angle
shot technique. For cervical vessels, a 3-dimensional fast imaging with
steady-state precession technique was also used during intravenous
administration of a gadolinium bolus.
TABLE 1. Characteristics of the 13 Acute Stroke Patients Who
Underwent Both Perfusion CT and DWI or PWI at the Time of
Emergency Evaluation
Patient Age, y Sex
Noncontrast CT
Findings
Location of DWI
Abnormality
1 51 F Normal Superficial left MCA
2 64 M Normal Right MCA
3* 71 M Insula ribbon sign Superficial left MCA
4 82 F Insula ribbon sign Left MCA and PCA
5† 71 M Hypodensity and insula
ribbon sign
Superficial left MCA
6 47 F Normal Right MCA
7 61 M Insula ribbon sign Superficial right MCA
8 61 M Normal Right MCA
9 50 M Hypodensity, basal
nuclei obscuration, and
insula ribbon sign
Left MCA
10 79 F Normal Left MCA
11 68 M Hypodensity and insula
ribbon sign
Superficial left MCA
12 77 M Normal Left MCA
13 75 M Hypodensity, insula
ribbon sign, and
hyperdense MCA
Right MCA
PCA indicates posterior cerebral artery.
*See Figure 1.
†See Figure 2.
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Data Processing
Perfusion CT data consist of time–contrast enhancement curves
registered in each pixel, with the curves linearly related to the
time-concentration curves for the iodinated contrast material. The
perfusion CT data were analyzed by use of a homemade perfusion
CT software (demonstrated at Radiological Society of North Amer-
ica, Chicago, Ill, 2001, and European Congress of Radiology,
Vienna, Austria, 2002), the results of which have been validated by
comparison with stable xenon CT.34 This software relies on the
central volume principle, which is the most accurate for low injection
rates of iodinated contrast material.37 The central volume principle
uses a mathematical operation called deconvolution (least-mean-
square deconvolution for the software used) to calculate a related
mean transit time (MTT).38–40 The deconvolution operation requires
a reference arterial input function, the selection of which is automat-
ically performed by the perfusion CT software used in a region of
interest drawn by the user. Considering that all our patients were
MCA stroke patients, time-concentration curves in each cerebral
hemisphere have been deconvoluted by ipsilateral sylvian arterial
input functions. The CBV map is inferred from a quantitative
measurement of the partial size–averaging effect, which is absent at
the center of the large superior sagittal venous sinus.41–43 Finally, a
simple equation combining CBV and MTT values leads to the CBF
value38–40: CBF(CBV/MTT). The perfusion CT results were then
used to calculate the penumbra and infarct maps according to a
previously reported method.35 This method relies on the reported
CBF threshold of ischemia and the preserved (penumbra) or the
altered (infarct) autoregulatory processes. Thus, in this method, an
ischemic cerebral area (penumbra plus infarct) was defined as
including cerebral pixels with a CBF decrease of 34% compared
with the corresponding region in the cerebral hemisphere defined as
healthy on the basis of clinical symptoms. Within this selected area,
pixels with CBV values higher or lower than 2.5 mL/100 g were
selected as indicative of penumbra and infarct, respectively. The
resulting cerebral infarct and penumbra maps were combined and
graphically displayed as a prognostic map, with the penumbra in
green and the infarct in red (Figures 1 and 2). The regional CBF and
regional CBV thresholds of 34% and 2.5 mL/100 g were chosen in
agreement with the values most frequently reported in the litera-
ture.15,44–47 Such thresholding, combined with adequate spatial
filtering, allows accurate infarct and penumbra maps, as demon-
strated by comparison with delayed DWI.35
The PWI data were analyzed with perfusion analysis software
(Functool, General Electric) and adequate postprocessing to create
parametric maps of relative CBF, CBV, MTT, and time to peak
(TTP), which designates the time to the peak signal change after the
bolus is injected. Analysis of PWI data relies on principles similar to
those applied to perfusion CT data but with some distinctions. Two
are particularly relevant in the present setting. First, time-intensity
curves in PWI are not linearly but logarithmically related to
time-concentration curves.48 Second, because of the susceptibility
properties that underlie PWI, the reference arterial input cannot be
selected within an arterial lumen, but only in the neighborhood of an
artery.48–50 This results in only qualitative or semiquantitative PWI
results (whereas perfusion CT results are quantitative34) for a variety
of reasons44 that are still a matter of debate and are beyond the scope
of this article. This also explains why we decided to use a planimetric
method in the calculations rather than a numeric threshold method
for determining the size of PWI abnormalities. Similar to what was
described in by Sorenson et al,8 2 neuroradiologists who were
blinded to each other were asked to determine the volume of
abnormal signal for each of the PWI maps. The average of the 2
neuroradiologists’ measurements was chosen as the reference for
MR studies. This method more closely simulates how PWI maps are
used in clinical practice.
Regarding DWI studies, abnormality size was measured on
trace-weighted images, which allow clear delineation of the abnor-
mal region because of the absence of interfering contrast between
normal gray and white matter. Average diffusion coefficient maps
were calculated and used to confirm that the trace abnormalities were
hyperacute.
Data Analysis
Six 5-mm-thick cerebral sections (with 1.5-mm gaps) in the DWI
and PWI sequences were selected to constitute the volume corre-
sponding most closely to that defined by the 4 adjacent 10-mm-thick
noncontrast CT and perfusion CT sections. For each patient, the
volumes (in milliliters) on corresponding noncontrast CT, perfusion
CT, and DWI or PWI maps were compared through linear regression
analysis with calculation of Pearson’s linear correlation coefficients.
Values of P0.001 were considered statistically significant.
Results
Time Delays
The median time from symptom onset to emergency room
admission was 1.5 hours (interquartile range, 1.3 to 2.0
Figure 1. A 71-year-old male patient with sudden onset of a
right face-arm-leg motor hemisyndrome associated with fluent
aphasia 1.5 hours before admission. Noncontrast cerebral CT
and perfusion CT were obtained 1.75 hours after symptom
onset, whereas DWI or PWI was performed 20 minutes after CT.
Noncontrast cerebral CT showed left insula ribbon sign. Sizes of
cerebral infarct and CBV abnormality on perfusion CT (mL/100
g) is similar to that of DWI abnormality, whereas MR CBV map
is unremarkable. Sizes of cerebral ischemic lesion and CBF/MTT
abnormality on perfusion CT [(mL · 100 g1 · min1)/s] correlate
with that of MR MTT abnormality (red) located on the left tem-
poroparietal region, whereas they are larger than those of MR
CBF and TTP abnormalities (red). CT-angiography and
MR-angiography demonstrate occlusion of the left M1-M2 junc-
tion. This patient underwent successful thrombolysis with signifi-
cant regression of symptoms.
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hours); the median time from symptom onset to perfusion CT
scanning was 2.0 hours (interquartile range, 2.0 to 2.8 hours).
The median time to MR examination was 2.5 hours (inter-
quartile range, 2.5 to 3.0 hours). Of the 13 patients, 9
underwent intravenous thrombolytic therapy. Thrombolysis
was begun 2.8 hours (interquartile range, 2.5 to 2.8 hours)
after symptom onset. No complications, in particular no
hemorrhages, occurred in the 9 thrombolyzed patients.
Arterial Recanalization or Persistent
Arterial Occlusion
In all 13 patients, admission CT-angiography demonstrated
an occluded cerebral artery. In all of them, this cerebral
arterial occlusion persisted on the MR-angiography and on
PWI sequences.
Correlation Between Perfusion CT and DWI or
PWI Results
The median size of cerebral hypodensity on noncontrast CT
amounted to 0 mL (interquartile range, 0 to 4 mL). The
median sizes of infarct and penumbra on perfusion CT were
19 and 120 mL (interquartile ranges, 14 to 44 and 80 to 140
mL, respectively). The median sizes of CBV, DWI, CBF,
TTP, and MTT abnormalities amounted to 13, 21, 58, 96, and
129 mL (12 to 29, 14 to 42, 34 to 67, 58 to 125, and 98 to 168
mL), respectively.
The results of the linear regression analysis are summarized
in Table 2 and are as follows. The size of CT hypodensity
underestimates that of abnormalities on all perfusion CT and
DWI or PWI maps (slopes 1). The perfusion CT infarct is
larger than the MR CBV abnormality (slope 1), approxi-
mately equal to the DWI abnormality (slope almost unity),
and smaller than the MR CBF, TTP, and MTT abnormalities.
The correlation coefficient is the highest (r0.968) and the
probability values are the smallest (P0.001) between the
size of perfusion CT infarct and that of the DWI abnormality
(Figure 3).
The perfusion CT ischemia (infarct plus penumbra) is
larger than the MR CBV, DWI, CBF, and TTP abnormalities
(slope 1) and approximately equal to the MR MTT abnor-
mality (slope almost unity). The correlation coefficient is the
highest (r0.946) and the probability values are the smallest
(P0.001) between the size of perfusion CT ischemia and
that of MR MTT abnormality (Figure 4). These results are
illustrated in Figures 1 and 2.
Discussion
Only 13 patients could be enrolled in this study over 16
months. This limited number related mainly to the difficulty
in obtaining MR examinations in the acute phase. Indeed, in
our institution as in many others, MRI remains of limited
availability in emergency settings because of overcrowded
MR units and the absence of an MR scanner devoted to stroke
patients.
On the other hand, perfusion CT can be easily achieved
because it can be included in the cerebral CT survey under-
gone by almost every stroke patient.35,51–53 Such CT survey,
including noncontrast CT, 2 perfusion CT series, and CT-
angiography, can be performed in 10 minutes. Perfusion
CT is well tolerated by patients, even in the acute phase of
stroke.35,51–53
The purpose of this study was to compare admission
perfusion CT and admission DWI and PWI results. This
comparison was allowed by the short time interval (median
interval, 30 minutes) and by the absence of arterial recanali-
zation between both examinations.
Our results outline a strong correlation between the size of
cerebral infarct on perfusion CT and that of DWI abnormality
(r0.968), with a slope close to unity. The perfusion CT
cerebral infarct is thus in agreement with the current opinion
that DWI abnormality is unlikely to reverse and hence most
likely correlates with the final infarct volume.54 On the other
hand, the size of the MR CBV abnormality underestimates
both the sizes of cerebral infarct on perfusion CT and that of
DWI abnormality (slope1.229), even if these sizes are
Figure 2. A 71-year-old male patient with sudden onset of a
right face-arm-leg hemisyndrome associated with nonfluent
aphasia. Noncontrast cerebral CT/perfusion CT and DWI or PWI
were performed 2 and 2.3 hours after symptom onset, respec-
tively. Noncontrast cerebral CT demonstrates left insula ribbon
sign and left parietal hypodensity. MR CBV map is normal.
Cerebral infarct and CBV abnormality on perfusion CT (mL/100
g) show sizes similar to that of DWI abnormality. Cerebral ische-
mic lesion and CBF MTT abnormality on perfusion CT [(mL ·
100 g1 · min1)/s] and MR MTT abnormality (red) involve the
whole left MCA territory, relating to an M1 occlusion on both
CT-angiography and MR-angiography. This patient underwent
unsuccessful thrombolysis.
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significantly correlated (r0.948). The underestimation of
the size of the MR CBV abnormality induces in turn an
underestimation of the size of the MR CBF abnormality
because the latter proves equal to the CBV-to-MTT ratio.
Cerebral parenchyma with PWI abnormalities that do not
yet show as ischemic on DWI has been postulated to
represent penumbra.26,28–31 PWI abnormalities can be char-
acterized by different parameters. Among them, MTT is an
easy-to-interpret parameter that is homogeneous in normal
areas, allowing easy identification of abnormal hemodynam-
ics.29,30 A strong correlation was identified between the size
of the MR MTT abnormality and the size of what is described
by perfusion CT as cerebral tissue at risk for inclusion into the
final infarct (r0.946). This result is in agreement with
previous reports demonstrating deconvolution methods as the
most accurate in PWI result analysis.55
On the other hand, the size of the MR TTP abnormality
underestimates the size of cerebral ischemia on perfusion CT
and the size of the MR MTT abnormality. The TTP map
describes changes in the arrival timing of blood to the
ischemic area rather than decreased perfusion and is thus
affected by parent vessel stenosis. TTP abnormalities do not
necessarily reflect the severity of the perfusion deficit.9
Finally, the size of hypodensity on noncontrast cerebral CT
underestimates that of all perfusion CT, DWI, and PWI
abnormalities, which is in agreement with the fact that CT
studies become typically abnormal only 6 to 18 hours after
the onset of ischemia.
As described in Materials and Methods, brain coverage
with perfusion CT was limited to a 40-mm thickness, whereas
the whole brain can be assessed with DWI or PWI. As
reported in Table 1, all 13 patients included in the present
study were MCA stroke patients. In 0 of these 13 patients, the
abnormalities seen on DWI or PWI examinations were
located completely outside the 40-mm thickness covered by
perfusion CT. In fact, the major portion of the cerebral
ischemic area could be evaluated by perfusion CT. However,
such a condition could occur, and limited coverage consti-
tutes a limitation of perfusion CT technique, even if techno-
logical improvements in the near future will overcome this
obstacle.
Finally, our cerebral CT survey protocol in stroke patients
involves a total amount of 150 mL iodinated contrast mate-
rial, which is rather high. Some concern may be raised about
potential toxicity of iodinated contrast material on ischemic
brain. In the present series, we never observed any deterio-
ration in neurological condition after intravenous administra-
tion of iodinated contrast material. Cerebral digital subtracted
angiography involves comparable volumes of iodinated con-
trast material but with a much higher blood concentration
because of intra-arterial administration. Angiography, how-
ever, is often resorted to in the setting of strokes and remains
a gold standard for stroke treatment. Finally, intravenous
administration of nonionic iodinated contrast material has
been demonstrated to be safe for ischemic cerebral paren-
chyma in animals.56
In conclusion, perfusion CT is an imaging technique that
allows delineation of cerebral infarct and cerebral tissue at
Figure 3. Significant correlation between the sizes of perfusion
CT infarct and DWI abnormality (slope0.913, r0.968,
P0.001).
Figure 4. Significant correlation between the sizes of perfusion
CT ischemia (infarct plus penumbra) and MR MTT abnormality
(slope0.905, r0.946, P0.001).
TABLE 2. Comparison Between Abnormality Sizes on Perfusion CT and DWI or PWI
x-Axis
y Axis
CT Hypodensity Perfusion CT Infarct Perfusion CT Ischemia (Infarct Plus Penumbra)
Slope r P Slope r P Slope r P
MR CBV abnormality 0.479 0.419 0.195 1.229 0.948 0.007 1.572 0.685 0.059
DWI abnormality 0.425 0.671 0.223 0.913 0.968 0.001 1.415 0.342 0.410
MR CBF abnormality 0.270 0.541 0.110 0.656 0.682 0.011 1.242 0.706 0.055
MR TTP abnormality 0.199 0.270 0.421 0.752 0.674 0.033 1.184 0.665 0.025
MR MTT abnormality 0.291 0.436 0.190 0.669 0.663 0.026 0.905 0.946 0.001
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risk for inclusion into the final infarct, which are strongly
correlated with DWI and PWI (MTT) MR results. The
advantages of perfusion CT compared with DWI or PWI are
related to its accessibility and its feasibility in acute stroke
patients, as well as to the rapidity of data acquisition.
Perfusion CT can be easily included in patients’ imaging
surveys at the time of their emergency evaluation. Brain
coverage, however, remains more limited with perfusion CT
than with DWI or PWI, and iodinated contrast material
administration is required, although no toxicity of the latter
could be observed.
Acknowledgments
We wish to acknowledge the skillful assistance of S. Behzad, chief
MR technologist in the Department of Diagnostic and Interventional
Radiology. We thank M. Rousselle for her help in editing the
manuscript.
References
1. National Institute of Neurological Disorders and Stroke (NINDS) rt-PA
Stroke Study Group. Tissue plasminogen activator for acute ischaemic
stroke. N Engl J Med. 1995;33:1581–1587.
2. American Heart Association. Stroke Facts. Dallas, Tex: American Heart
Association; 1999.
3. Hennerici M. Improving the outcome of acute stroke management. Hosp
Med. 1999;60:44–49.
4. Zaheer A, Ozsunar Y, Schaefer PW. Magnetic resonance imaging of
cerebral hemorrhagic stroke. Top Magn Reson Imaging. 2000;11:
288–299.
5. Mayer TE, Schulte-Altedorneburg G, Droste DW, Brückmann H. Serial
CT and MRI of ischaemic cerebral infarcts: frequency and clinical impact
of haemorrhagic transformation. Neuroradiology. 2000;42:233–239.
6. Hacke W, Kaste M, Fieschi C. Randomised double-blind trial placebo-
controlled trial of thrombolytic therapy with intravenous therapy with
intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet.
1998;352:1245–1251.
7. Oppenheim C, Samson Y, Manai R, Lalam T, Vandamme X, Crozier S,
Srour A, Cornu P, Dormont D, Rancurel G, Marsault C. Prediction of
malignant middle cerebral artery infarction by diffusion-weighted
imaging. Stroke. 2000;31:2175–2185.
8. Sorensen AG, Copen WA, Ostergaard L, Buonanno FS, Gonzalez RG,
Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Koroshetz
WJ. Hyperacute stroke: simultaneous measurement of relative cerebral
blood volume, relative cerebral blood flow, and mean tissue transit time.
Radiology. 1999;210:519–527.
9. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks
MP. Longitudinal magnetic resonance imaging study of perfusion and
diffusion in stroke: evolution of lesion volume and correlation with
clinical outcome. Ann Neurol. 1999;46:568–578.
10. Rubin G, Firlik AD, Levy EI, Pindzola RR, Yonas H. Relationship
between cerebral blood flow and clinical outcome in acute stroke. Cere-
brovasc Dis. 2000;10:298–306.
11. Karonen JO, Nuutinen J, Kuikka JT, Vanninen EJ, Vanninen RL,
Partanen PL, Vainio PA, Roivainen R, Sivenius J, Aronen HJ. Combined
SPECT and diffusion-weighted MRI as predictor of infarct growth in
acute ischemic stroke. J Nucl Med. 2000;41:788–794.
12. Ezura M, Takahashi A, Yoshimoto T. Evaluation of regional cerebral
blood flow using single photon emission tomography for the selection of
patients for local fibrinolytic therapy of acute cerebral embolism. Neu-
rosurg Rev. 1996;19:231–236.
13. Heiss WD, Grond M, Thiel A, von Stockhausen HM, Rudolf J. Ischemic
brain tissue salvaged from infarction with alteplase. Lancet. 1997;349:
1599–1600.
14. Hossmann KA. Neuronal survival and revival during and after cerebral
ischemia. Am J Emerg Med. 1994;1:191–197.
15. Hossmann KA. Viability thresholds and the penumbra of focal ischemia.
Ann Neurol. 1994;36:557–565.
16. Astrup J, Symon L, Siesjö BK. Thresholds in cerebral ischemia: the
ischemic penumbra. Stroke. 1981;12:723–725.
17. Symon L, Branston NM, Strong AJ, Hope TD. The concepts of thresholds
of ischaemia in relation to brain structure and function. J Clin Pathol.
1977;30(suppl):149–154.
18. Heiss WD. Ischemic penumbra: evidence from functional imaging in
man. J Cereb Blood Flow Metab. 2000;20:1276–1293.
19. Kluytmans M, van Everdingen KJ, Kappelle LJ, Ramos LM, Viergever
MA, van der Grond J. Prognostic value of perfusion- and diffusion-
weighted MR imaging in first 3 days of stroke. Eur Radiol. 2000;10:
1434–1441.
20. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J,
Derugin N, Asgari H, Norman D. Diffusion-weighted MR imaging of
acute stroke: correlation with T2-weighted and magnetic susceptibility
enhanced MR imaging in cats. AJNR Am J Neuroradiol. 1990;11:
423–429.
21. Moseley ME, Cohen Y, Mintorovitch J, Chileuitt L, Shimizu H,
Kucharczyk J, Wendland MF, Weinstein PR. Early detection of regional
cerebral ischemia in cats: comparison of diffusion and T2-weighted MRI
and spectroscopy. Magn Reson Med. 1990;210:155–162.
22. Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF,
Rordorf G, Wang B, Sorensen AG, Koroshetz WJ. Diffusion-weighted
MR imaging: diagnostic accuracy in patients imaged within 6 hours of
stroke symptom onset. Radiology. 1999;210:155–162.
23. Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic
resonance diffusion-weighted imaging of acute human stroke. Neurology.
1992;42:1717–1723.
24. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman R. Acute human
stroke studied by whole brain echo planar diffusion-weighted magnetic
resonance imaging. Ann Neurol. 1995;37:231–241.
25. Baird A, Warach S. Magnetic resonance imaging of acute stroke. J Cereb
Blood Flow Metab. 1998;18:41–47.
26. Busza AL, Allen KL, King MD, van Bruggen N, Williams SR, Gadian
DG. Diffusion-weighted imaging studies of cerebral ischemia in gerbils:
potential relevance to energy failure. Stroke. 1992;10:1602–1612.
27. Warach S, Li W, Ronthal M, Edelman R. Acute cerebral ischemia:
evaluation with dynamic contrast-enhanced MR imaging and MR
angiography. Radiology. 1992;182:41–47.
28. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH,
Huang-Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela
N, Can U, Moreira JA, Copen WA, Look RB, Finklestein SP, Rosen BR,
Koroshetz WJ. Hyperacute stroke: evaluation with combined multisection
diffusion-weighted and hemodynamically weighted echo-planar MR
imaging. Radiology. 1996;199:391–401.
29. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad KO, Edelman RR,
Warach S. Enlargement of human cerebral ischemic lesion volumes
measured by diffusion-weighted magnetic resonance imaging. Ann
Neurol. 1997;41:581–589.
30. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D,
Donnan GA, Tress BM, Davis SM. Prediction of stroke outcome with
echoplanar perfusion- and diffusion-weighted MRI. Neurology. 1998;51:
418–426.
31. Rordorf G, Koroshetz WJ, Copen WA, Cramer SC, Schaefer PW, Budzik
RF Jr, Schwamm LH, Buonanno F, Sorensen AG, Gonzalez G. Regional
ischemia and ischemic injury in patients with acute middle cerebral artery
stroke as defined by early diffusion-weighted and perfusion-weighted
MRI. Stroke. 1998;29:939–943.
32. Lövblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B,
Connor A, Burzynski C, Edelman RR, Warach S. Ischemic lesion
volumes in acute stroke by diffusion-weighted magnetic resonance
imaging correlate with clinical outcome. Ann Neurol. 1997;42:164–170.
33. van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali WP.
Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke.
1998;29:1783–1790.
34. Wintermark M, Maeder P, Thiran J-Ph, Schnyder P, Meuli R. Simulta-
neous measurements of regional cerebral blood flows by perfusion-CT
and stable xenon-CT: a validation study. AJNR Am J Neuroradiol. 2001;
22:905–914.
35. Wintermark M, Reichhart M, Thiran J-P, Maeder P, Schnyder P, Bogousslavsky
J, Meuli R. Prognostic accuracy of cerebral blood flow measurement by per-
fusion computed tomography, at the time of emergency room admission, in acute
stroke patients. Ann Neurol. 2002;51:417-432.
36. Wintermark M, Maeder P, Verdun FR, Thiran JP, Valley JF, Schnyder P,
Meuli R. Using 80 kVp versus 120 kVp in perfusion CT measurement of
regional cerebral blood flows. AJNR Am J Neuroradiol. 2000;21:
1881–1884.
2030 Stroke August 2002
37. Wintermark M, Maeder P, Thiran J-Ph, Schnyder P, Meuli R. Quanti-
tative assessment of regional cerebral blood flows by perfusion CT
studies at low injection rates: a critical review of the underlying theo-
retical models. Eur Radiol. 2001;11:1220–1230.
38. Axel L. Cerebral blood flow determination by rapid-sequence computed
tomography. Radiology. 1980;137:679–686.
39. Axel L. A method of calculating brain blood flow with a CT dynamic
scanner. Adv Neurol. 1981;30:67–71.
40. Axel L. Tissue mean transit time from dynamic computed tomography by
a simple deconvolution technique. Invest Radiol. 1983;18:94–99.
41. Ladurner G, Zilkha E, Iliff LD, du Boulay GH, Marshall J. Measurement
of regional cerebral blood volume by computerized axial tomography.
J Neurol Neurosurg Psychiatry. 1976;39:152–155.
42. Zilkha E, Ladurner G, Iliff LD, du Boulay GH, Marshall J. Computer
subtraction in regional cerebral blood-size measurements using the EMI-
scanner. Br J Radiol. 1976;49:330–334.
43. Ladurner G, Zikha E, Sager WD, Iliff LD, Lechner H, du Boulay GH.
Measurement of regional cerebral blood volume using the EMI 1010
scanner. Br J Radiol. 1979;52:371–374.
44. Harper AM. Autoregulation of cerebral blood flow: influence of the
arterial blood pressure on the blood flow through the cerebral cortex.
J Neurol Neurosurg Psychiatry. 1966;29:398–403.
45. Mayer TE, Hamann GF, Baranczyk J, Rosengarten B, Klotz E, Wiesmann
M, Missler U, Schulte-Altedorneburg G, Brueckmann HJ. Dynamic CT
perfusion imaging of acute stroke. AJNR Am J Neuroradiol. 2000;21:
1441–1449.
46. Hunter GJ, Hamberg LM, Ponzo JA, Huang-Hellinger FR, Morris PP,
Rabinov J, Farkas J, Lev MH, Schaefer PW, Ogilvy CS, Schwamm L,
Buonanno FS, Koroshetz WJ, Wolf GL, Gonzalez RG. Assessment of
cerebral perfusion and arterial anatomy in hyperacute stroke with three-
dimensional functional CT: early clinical results. AJNR Am J Neuro-
radiol. 1998;19:29–37.
47. Lee KH, Cho SJ, Byun HS, Na DG, Choi NC, Lee SJ, Jin IS, Lee TG,
Chung CS. Triphasic perfusion computed tomography in acute middle
cerebral artery stroke: a correlation with angiographic findings. Arch
Neurol. 2000;57:990–999.
48. Sorensen AG, Reimer P. Cerebral MR Perfusion Imaging: Principles and
Current Applications. New York, NY: Thieme Verlag; 2000.
49. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due
to intravascular magnetic susceptibility perturbations. Magn Reson Med.
1995;34:555–566.
50. Weisskoff R, Zuo C, Boxerman J, Rosen B. Microscopic susceptibility
variation and transverse relaxation: theory and experiment. Magn Reson
Med. 1994;31:610.
51. Koenig M, Klotz E, Luka B, Venderink DJ, Spittler JF, Heuser L.
Perfusion CT of the brain: diagnostic approach for early detection of
ischemic stroke. Radiology. 1998;209:85–93.
52. Mayer TE, Hamann GF, Baranczyk J, Rosengarten B, Klotz E, Wiesmann
M, Missler U, Schulte-Altedorneburg G, Brueckmann HJ. Dynamic CT
perfusion imaging of acute stroke. AJNR Am J Neuroradiol. 2000;21:
1441–1449.
53. Eastwood JD, Lev MH, Azhari T, Lee TY, Barboriak DP, Delong DM,
Fitzek C, Herzau M, Wintermark M, Meuli R, Brazier D, Provenzale JM.
CT perfusion scanning with deconvolution analysis: pilot study in
patients with acute middle cerebral artery stroke. Radiology. 2002;222:
227–236.
54. Grant PE, He J, Wu O, Schaefer PW, Schwamm LH, Budzik RF,
Sorensen AG, Koroshetz WJ, Gonzalez RG. Frequency and clinical
context of decreased apparent diffusion coefficient reversal in the human
brain. Radiology. 2001;221:43–50.
55. Yamada K, Wu O, Gonzalez RG, Bakker D, Ostergaard L, Copen WA,
Weisskoff RM, Rosen BR, Yagi K, Nishimura T, Sorensen AG. Magnetic
resonance perfusion-weighted imaging of acute cerebral infarction: effect
of the calculation methods and underlying vasculopathy. Stroke. 2002;
33:87–94.
56. Doerfler A, Engelhorn T, von Kummer R, Weber J, Knauth M, Heiland
S, Sartor K, Forsting M. Are iodinated contrast agents detrimental in
acute cerebral ischemia? An experimental study in rats. Radiology. 1998;
206:211–217.
Wintermark et al Perfusion CT and Qualitative DWI/PWI 2031
